Walleye Trading
VIR icon

Walleye Trading’s Vir Biotechnology VIR Stock Holding History

Walleye Trading’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,500
Closed -$77.1K – 4859
2025
Q3 		$77.1K Hold
13,500
– – ﹤0.01% 3824
2025
Q2 		$68K Buy
+13,500
New +$72.4K ﹤0.01% 3737
2023
Q3 		– Sell
-11,200
Closed -$275K – 5403
2023
Q2 		$275K Sell
11,200
-7,900
-41% -$198K ﹤0.01% 3225
2023
Q1 		$444K Buy
+19,100
New +$489K ﹤0.01% 2899
2022
Q1 		– Sell
-21,900
Closed -$917K – 5947
2021
Q4 		$917K Sell
21,900
-17,400
-44% -$682K ﹤0.01% 2309
2021
Q3 		$1.71M Buy
+39,300
New +$1.7M 0.01% 1741
2021
Q1 		– Sell
-5,200
Closed -$139K – 5339
2020
Q4 		$139K Buy
+5,200
New +$169K ﹤0.01% 3755

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Walleye Trading's VIR Position: Q4 2025 in Review

Walleye Trading sold out of Vir Biotechnology (VIR) in Q4 2025, closing a stake of 1,940 shares — an estimated $11.1K sold.

Walleye Trading first reported a position in VIR in Q3 2021 and held it in 4 quarters. The position peaked at $880K in Q3 2021. 218 funds tracked by Wall St. Rank hold VIR as of Q4 2025.

  • Walleye Trading reported no remaining Vir Biotechnology position as of Q4 2025 after selling out during the quarter.
  • Walleye Trading sold 1,940 Vir Biotechnology shares in Q4 2025, an estimated $11.1K.
  • Walleye Trading first reported a position in Vir Biotechnology in Q3 2021 and held it in 4 quarters.
  • Walleye Trading's Vir Biotechnology position peaked at $880K in Q3 2021.
  • 218 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2025.

Based on Walleye Trading's 13F filing for Q4 2025, filed 13 Feb 2026.